These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 12066206)
1. Late course accelerated hyperfractionation radiotherapy concomitant with cisplatin in patients with esophageal carcinoma. Gao XS; Qiao XY; Yang XR; Asaumi J; Zhou ZG; Wang YD; Zhou DA; Wan J; Kuroda M; Kishi K; Kawasaki S; Hiraki Y Oncol Rep; 2002; 9(4):767-72. PubMed ID: 12066206 [TBL] [Abstract][Full Text] [Related]
2. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma]. Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288 [TBL] [Abstract][Full Text] [Related]
3. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy. Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360 [TBL] [Abstract][Full Text] [Related]
4. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179 [TBL] [Abstract][Full Text] [Related]
5. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma]. An FS; Huang JQ; Xie YT; Chen SH; Rong TH Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571 [TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243 [TBL] [Abstract][Full Text] [Related]
7. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Zhao KL; Shi XH; Jiang GL; Yao WQ; Guo XM; Wu GD; Zhu LX Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1014-20. PubMed ID: 15990003 [TBL] [Abstract][Full Text] [Related]
8. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer. Tanaka A; Ishikawa S; Okuno K; Shiozaki H Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308 [TBL] [Abstract][Full Text] [Related]
9. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862 [TBL] [Abstract][Full Text] [Related]
10. Results of radiation therapy for superficial esophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Nemoto K; Yamada S; Nishio M; Aoki M; Nakamura R; Matsumoto Y; Sasamoto R; Saitoh Y; Takayama M; Mitsuhashi N; Gomi K; Kanesaka N; Kobayashi M; Ohnishi H; Sasaki S; Tamamura H; Mitsumori M; Nishimura Y; Tsujino K; Takemoto M; Uchida N; Yamamoto M; Shioyama Y; Hirakawa K; Ono S; Anticancer Res; 2006; 26(2B):1507-12. PubMed ID: 16619565 [TBL] [Abstract][Full Text] [Related]
11. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Kumar S; Dimri K; Khurana R; Rastogi N; Das KJ; Lal P Radiother Oncol; 2007 May; 83(2):139-47. PubMed ID: 17445928 [TBL] [Abstract][Full Text] [Related]
12. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)]. Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ; Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962 [TBL] [Abstract][Full Text] [Related]
13. A phase II trial of chemoradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Kato H; Sato A; Fukuda H; Kagami Y; Udagawa H; Togo A; Ando N; Tanaka O; Shinoda M; Yamana H; Ishikura S Jpn J Clin Oncol; 2009 Oct; 39(10):638-43. PubMed ID: 19549720 [TBL] [Abstract][Full Text] [Related]
14. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). Katori H; Tsukuda M; Watai K Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160 [TBL] [Abstract][Full Text] [Related]
15. Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy. Ishikawa H; Sakurai H; Tamaki Y; Nonaka T; Yamakawa M; Saito Y; Kitamoto Y; Higuchi K; Hasegawa M; Nakano T J Gastroenterol Hepatol; 2006 Aug; 21(8):1290-6. PubMed ID: 16872312 [TBL] [Abstract][Full Text] [Related]
16. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518 [TBL] [Abstract][Full Text] [Related]
17. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Mariette C; Piessen G; Lamblin A; Mirabel X; Adenis A; Triboulet JP Br J Surg; 2006 Sep; 93(9):1077-83. PubMed ID: 16779882 [TBL] [Abstract][Full Text] [Related]
18. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643 [TBL] [Abstract][Full Text] [Related]
19. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy. Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767 [TBL] [Abstract][Full Text] [Related]
20. Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck. Jeremic B; Milicic B; Dagovic A; Vaskovic Z; Tadic L J Clin Oncol; 2004 Sep; 22(17):3540-8. PubMed ID: 15337803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]